Chengdu Pukangweixin Biotechnology CO.,LTD.

Chengdu Pukang Biotechnology Co., Ltd. is located in the national cross-strait science and Technology Industrial Development Park - Chengdu Wenjiang cross-strait science and Technology Park, specializing in the long-term development of peptide drugs for chronic diseases

FA is a production-oriented enterprise integrating R & D, production and sales. At present, the company has a R & D center of 2400 square meters and a production workshop of 1000 square meters, and plans to build a production base of 12000 square meters

In accordance with GMP standards, quality system management.

              The company's main products are: high purity single molecular weight PEG derivatives, hydroxyproline derivatives, peptide long-acting drug modified side chain and its intermediates (somaruptide side chain, liraglutide side chain)

Peptide side chain, degu insulin side chain, long-term hormone production, and short peptide drug modified side chain (somaruptide dipeptide, tetrapeptide).

      The company, together with innovative drug enterprises, creates a long-term peptide drug research and development platform, and is committed to creating a systematic and diverse long-term side chain library, establishing molecular fragments of long-term peptide side chain, and developing long-term peptide drugs for customers

Drugs provide a variety of development solutions.

            Adhering to the concept of "quality first, science and technology leading", the company provides global customers with the best products and services.